Deciphera Pharmaceuticals Inc (DCPH)
25.46
+0.02
(+0.06%)
USD |
NASDAQ |
May 17, 16:00
25.46
0.00 (0.00%)
After-Hours: 20:00
Deciphera Pharmaceuticals Total Return Level: 25.46 for May 17, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 17, 2024 | 25.46 |
May 16, 2024 | 25.45 |
May 15, 2024 | 25.45 |
May 14, 2024 | 25.44 |
May 13, 2024 | 25.42 |
May 10, 2024 | 25.36 |
May 09, 2024 | 25.37 |
May 08, 2024 | 25.37 |
May 07, 2024 | 25.38 |
May 06, 2024 | 25.37 |
May 03, 2024 | 25.38 |
May 02, 2024 | 25.38 |
May 01, 2024 | 25.36 |
April 30, 2024 | 25.27 |
April 29, 2024 | 25.28 |
April 26, 2024 | 14.65 |
April 25, 2024 | 14.18 |
April 24, 2024 | 14.62 |
April 23, 2024 | 14.67 |
April 22, 2024 | 14.58 |
April 19, 2024 | 14.67 |
April 18, 2024 | 14.23 |
April 17, 2024 | 14.72 |
April 16, 2024 | 14.84 |
April 15, 2024 | 14.90 |
Date | Value |
---|---|
April 12, 2024 | 15.05 |
April 11, 2024 | 15.52 |
April 10, 2024 | 15.61 |
April 09, 2024 | 15.64 |
April 08, 2024 | 15.01 |
April 05, 2024 | 15.34 |
April 04, 2024 | 15.14 |
April 03, 2024 | 15.29 |
April 02, 2024 | 15.19 |
April 01, 2024 | 15.76 |
March 28, 2024 | 15.73 |
March 27, 2024 | 15.18 |
March 26, 2024 | 14.82 |
March 25, 2024 | 15.30 |
March 22, 2024 | 15.23 |
March 21, 2024 | 15.50 |
March 20, 2024 | 15.75 |
March 19, 2024 | 14.97 |
March 18, 2024 | 14.85 |
March 15, 2024 | 15.59 |
March 14, 2024 | 15.91 |
March 13, 2024 | 15.98 |
March 12, 2024 | 16.09 |
March 11, 2024 | 16.54 |
March 08, 2024 | 16.94 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
6.87
Minimum
Mar 07 2022
69.93
Maximum
Dec 17 2019
28.86
Average
21.54
Median
Jul 29 2019
Total Return Level Benchmarks
Bristol-Myers Squibb Co | 176.18 |
Dynavax Technologies Corp | 11.11 |
Gilead Sciences Inc | 92.08 |
Esperion Therapeutics Inc | 2.36 |
SINTX Technologies Inc | 0.085 |